Normal human diploid fibroblasts (HDFs) are refractory to oncogene-mediated transformations in vitro, compared with rodent fibroblasts. As successful oncogene-mediated transformations of normal HDFs have been reported using the human telomerase catalytic subunit, it has been considered that telomerase activity contributes to the species-specific transformability. However, these transformed HDFs are much less malignant compared with those of rodent cells, suggesting the existence of undefined mechanisms that render HDFs resistant to malignant transformation. Here, cDNA microarray analysis identified caveolin-1 as one of the possible cellular factors involved in such mechanisms. The mitogen-activated protein kinases (MAPK) pathway downregulates Caveolin-1 in rodent fibroblasts, transformed by coexpression of the SV40 early region and activated H-Ras. In contrast, the coexpression of these two oncogenes in HDFs failed to reduce the expression level of Caveolin-1. These results strongly suggest the presence of critical differences in events following the phosphorylation of ERK during the activation process of the MAPK signaling pathway between human and rodent cells, as the ERK protein was similarly phosphorylated in both systems. Furthermore, the small interfering RNA-mediated suppression of Caveolin-1 facilitated the oncogene-mediated transformation of normal HDFs, clearly indicating that the differences in the transformability between human and rodent cells are due, at least in part, to the mechanism responsible for the resistance to Ras-induced Caveolin-1 downregulation in HDFs.
Normal human diploid fibroblasts (HDFs) are refractory to oncogene-mediated transformations in vitro, compared with rodent fibroblasts. As successful oncogene-mediated transformations of normal HDFs have been reported using the human telomerase catalytic subunit, it has been considered that telomerase activity contributes to the species-specific transformability. However, these transformed HDFs are much less malignant compared with those of rodent cells, suggesting the existence of undefined mechanisms that render HDFs resistant to malignant transformation. Here, cDNA microarray analysis identified caveolin-1 as one of the possible cellular factors involved in such mechanisms. The mitogen-activated protein kinases (MAPK) pathway downregulates Caveolin-1 in rodent fibroblasts, transformed by coexpression of the SV40 early region and activated H-Ras. In contrast, the coexpression of these two oncogenes in HDFs failed to reduce the expression level of Caveolin-1. These results strongly suggest the presence of critical differences in events following the phosphorylation of ERK during the activation process of the MAPK signaling pathway between human and rodent cells, as the ERK protein was similarly phosphorylated in both systems. Furthermore, the small interfering RNA-mediated suppression of Caveolin-1 facilitated the oncogene-mediated transformation of normal HDFs, clearly indicating that the differences in the transformability between human and rodent cells are due, at least in part, to the mechanism responsible for the resistance to Ras-induced Caveolin-1 downregulation in HDFs. Keywords: caveolin-1; hTERT; normal human diploid fibroblast; oncogenic transformation; Ras-MAPK pathway Although primary rodent cells are easily transformed by two concomitantly introduced oncogenes, primary human cells have proven to be refractory to transformation by numerous combinations of cellular and viral oncoproteins, indicating the fundamental difference in requirements for transformation in human versus rodent cells (Hahn and Weinberg, 2002; Akagi, 2004; Zhao et al., 2004) . Hahn et al. (1999) clearly showed that the combinations of human telomerase catalytic subunit (hTERT), SV40 early region (SV40ER) and activated H-Ras (H-RasV12) were necessary and sufficient for normal human foreskin fibroblasts and kidney epithelial cells to be transformed. By using the same combinations of genetic elements, they succeeded in the malignant transformation of several different types of normal human cells, and based on these data, they proposed that hTERT activity might contribute to the difference in the transformability between human and rodent cells (Hahn and Weinberg, 2002; Akagi, 2004; Zhao et al., 2004) . There is little doubt that hTERT is one of the most important factors responsible for the resistance of normal human cells with respect to oncogenic transformation. However, when the susceptibility to oncogenemediated transformation was compared between hTERT-expressing normal human diploid fibroblasts (HDFs) and normal rat embryo fibroblast (REF) cells under the same conditions, the transformation phenotypes of HDFs were much more limited than those of rodent cells (Akagi et al., 2003; Sukezane et al., 2005) . Therefore, it is likely that HDFs still have undefined intrinsic mechanisms responsible for the refractoriness with respect to oncogene-mediated transformation.
The coexpression of SV40ER (S) and H-RasV12 (R) is sufficient for REF and mouse embryo fibroblast (MEF) cells to be transformed but not for hTERTexpressing human lung fibroblasts, TIG3 cells, (TIG3/T cells) (Figure 1a and b) , which are the most resistant of the HDF strains to oncogenic transformation (Akagi et al., 2003) . We have compared the gene expression profiles of MEF, REF and TIG3/T cells expressing SV40ER in the presence or absence of H-RasV12, revealing that TIG3/TS cells are significantly more refractory to Ras-induced alteration of gene expression (Kakumoto et al., 2006) . The detailed analysis of the microarray data identified 53 genes, whose expression was reduced in MEF/S and REF/S cells but not in TIG3/TS cells, by the expression of H-RasV12 (Table 1) . It is possible that some of them may contribute to the species-specific transformability, acting as tumor suppressor genes. As a first step, we focused on Caveolin-1, which directly binds to various signaling molecules and mediates a number of cellular functions (Smart et al., 1999; Sasai et al., 2003; Tang et al., 2004) . As Caveolin-1 induces premature senescence in primary fibroblasts (Volonte et al., 2002) , negatively regulates cell cycle progression (Galbiati et al., 2001) , and inhibits anchorage-independent growth of cancer cells (Fiucci et al., 2002) , it is widely acknowledged that Caveolin-1 functions as a tumor suppressor.
The microarray data were confirmed by reverse transcription-polymerase chain reaction (RT-PCR) analysis, in which the mRNA level of caveolin-1 was reduced by the expression of H-RasV12 in rat cells but not in human cells (Figure 1c) . The immnoblot analyses also demonstrated that the expression of H-RasV12 decreased the protein levels of Caveolin-1 in MEF/S and REF/S cells but not in TIG3/TS cells (Figure 1d) . Furthermore, Caveolin-1 was highly expressed in the other three HDF strains expressing hTERT, SV40ER and H-RasV12 (Figure 1d) , with all of the HDF strains tested proving to be refractory to oncogene-mediated transformation (Akagi et al., 2003) , clearly indicating and then subcloned into a pCX4bleo vector (GenBank # AB086388). The method for retroviral-mediated gene transfer was described in previous report (Akagi et al., 2003) . ( for rat and human glyceraldehydes-3-phosphate dehydrogenase (g3pdh). g3pdh was employed as an internal control. (d) Expression levels of large-T antigen, Ras and caveolin-1 were analysed by immunoblotting, as described previously (Akagi et al., 2002 (Akagi et al., , 2003 ). An anticaveolin-1 rabbit polyclonal antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). and 931 genes (370 annotated genes) were differentially downregulated (ratio value oÀ1.5) by H-RasV12, respectively, and 86 annotated genes were commonly downregulated in both systems. Of 86 genes, 53 genes were not downregulated (ratio value >À1.5) by H-RasV12 in TIG3/TS cells. The list of these 53 genes was shown in an alphabetical order.
Caveolin-1 and transformation of human fibroblasts K Sasai et al the coexpression of SV40ER and H-RasV12, which is the most potent oncogene combination (Akagi, 2004) . The levels of Caveolin-1 protein were restored by the treatment of PD98059, a well-characterized inhibitor of mitogen-activated protein kinases (MAPK) kinase (MEK) (Figure 2a) , whose levels were almost identical to those in REF/S and MEF/S cells, indicating that the downregulation of Caveolin-1 observed in rodent systems primarily depended on the Ras-MAPK pathway. This result was consistent with the previous observation in Ras-transformed NIH3T3 cells (Galbiati et al., 1998) and prompted us to further investigate the MAPK pathway activity in HDFs. Interestingly, there were no obvious differences in phosphorylation levels of MEK and ERK proteins between human and rodent systems (Figure 2b) . Furthermore, the resistance to Rasinduced Caveolin-1 downregulation was also proven by reporter assays using the mouse promoter sequence (Figure 2c ). Thus, it is unlikely that the low level of ERK-phosphorylation in HDF/TSR cells or the speciesspecific sequence of caveolin-1 promoter was involved in the resistance.
Recently, we demonstrated that Ras-induced ERK activation was markedly attenuated in the HDF/TS cells compared with that in REF/S cells, despite no obvious differences in the phosphorylation status of ERK between the species (Kakumoto et al., 2006) . Therefore, qualitative or quantitative differences in the transcription factors, which are regulated by the Ras-MAPK pathway, may contribute to the species-specific resistance against the downregulation of Caveolin-1. We also found that the Ras-MAPK pathway upregulated Fra-1 (a member of AP-1 transcription factors) only in rodent fibroblasts (Kakumoto et al., 2006) , but ectopic overexpression of Fra-1 failed to reduce the Caveolin-1 level in TIG3 cells (data not shown). Interestingly, AP-1 binding activity was increased by the expression of RasV12 in REF/S cells but not in TIG3/TS cells, in spite of no obvious difference in the level of Jun phosphorylation (data not shown). Therefore, it remains possible that differences in AP-1 transcriptional activity may contribute to the refractoriness to Ras-induced downregulation of caveolin-1 in HDFs. Our microarray data and immnoblotting also identified that the expression of H-RasV12 downregulated the Foxo-1 transcription factor, which directly regulates Caveolin-1 expression (van den Heuvel et al., 2005) , in rodent systems but not in TIG3/TS cells (data not shown). As the downregulation of Foxo-1 correlates with cellular transformation (Accili and Arden, 2004) , it is possible that the MAPK pathway may regulate Caveolin-1 expression via Foxo-1 only in rodent cells, which may contribute to the refractoriness of HDFs with respect to oncogenemediated transformation.
Finally, in order to evaluate the effect of Caveolin-1 downregulation on the oncogenic transformation of normal HDFs, TIG3/TSR and BJ/TSR cells were transduced with a retroviral vector expressing a short interfering dsRNA for caveolin-1 (shCav422) (Ge and Pachter, 2004 ). These transduced cells were then selected with zeocine, resulting in a bulk population of 0 . The amplified fragment was digested by Hind III and Nco I, and then subcloned into the PGV-B2 vector (Toyo Ink, Tokyo, Japan). The resulting reporter plasmid was transfected with pEBB-His-LacZ plasmid, and the transfected cells were incubated for 48 h. The luciferase activity was then measured and normalized against the LacZ activity. The results were expressed as relative luciferase activity and shown in means7s.e. of triplicate experiment.
Caveolin-1 and transformation of human fibroblasts K Sasai et al HDF/TSR/shCav cells, in which the expression of endogenous Caveolin-1 was successfully inhibited (>50% reduction) and the extent of the downregulation was almost identical between REF/S and REF/SR cells (Figure 3a) . Although the knockdown of Cavolin-1 did not affect the cell morphology (Figure 3b , upper panels) and growth properties (data not shown) in adherent culture, soft-agar colony formation assays showed TIG3/TSR/shCav cells to form considerably higher numbers of colonies within 3 weeks compared to TIG3/TSR/shEGFP cells (Figure 3b , lower panels). These results were confirmed by an alternative vector system using DsRed as a marker of infection (data not shown). It should be noted that the majority of Figure 3 The downregulation of Caveolin-1 contributes transformation of TIG3/TSR cells. The dsDNA oligonucleotides encoding shRNAs for gene knockdown for EGFP (shEGFP122) (Chi et al., 2003) and Caveolin-1 (shCav422) were chemically synthesized and subcloned into pSIRENbleo retroviral vectors. The resulting vectors were then transduced into TIG3/TSR and BJ/TSR cells by retroviral-mediated gene transfer. Caveolin-1 and transformation of human fibroblasts K Sasai et al TIG3/TSR/shCav cells remained diploid (Figure 3c ). This is interesting because BJ/TSR cells, whose certain degree of transformation has been reported, were highly aneuploid (Hahn et al, 1999; Akagi et al, 2003) . Thus, it is speculated that the difference in the transformation phenotypes between TIG3/TSR and BJ/TSR cells partially depend on the degree of ploidy and chromosome instability. Since such partially transformed BJ/ TSR cells also became more malignant by the knockdown of Caveolin-1, as judged by the soft-agar colony formation assays (Figure 3c ), we concluded that the downregulation of Caveolin-1 contributes to the transformation of HDFs.
We were surprised to discover that the levels of ERK phosphorylation were not increased in TIG3/TSR/ shCav cells (Figure 3e ). This was unexpected as it has been reported that the downregulation of Caveolin-1 was sufficient to hyperactivate the MAPK pathway and drive cell transformation in rodent fibroblasts (Galbiati et al., 1998) . The contribution of the downregulation of Caveolin-1 to oncogenic transformation in TIG3/TSR cells may be independent of the MAPK pathway. As Caveolin-1 directly binds to a number of molecules other than MEK and ERK, and negatively regulates a variety of signaling pathway, including G-proteincoupled receptors and growth factor receptors (Smart et al., 1999) , those pathways might be activated in TIG3/ TSR/shCav cells and contribute to oncogenic transformation.
As the transformation degree of HDF/TSR/shCav cells is still lower than those of transformed rodent cells, other factors listed in Table 1 may also contribute to the refractoriness of normal HDFs with respect to oncogene-mediated transformation. However, we clearly demonstrated that the downregulation of Caveolin-1 was one of the important factors, which explain the fundamental difference in requirements for transformation in human versus rodent cells. Caveolin-1 À/À MEF cells showed a hyperproliferative phenotype (Razani et al., 2001 ) and the combined loss of caveolin-1 and ink4a increased their susceptibility to oncogenemediated transformation (Williams et al., 2004) . Furthermore, the senescent phenotype of HDF cells can be reversed by reduction of Caveolin-1 (Cho et al., 2003) . Thus, the loss or downregulation of Caveolin-1 is one of the genetic changes leading to alterations in proliferation, immortalization and transformation in both human and rodent systems whereas the detailed molecular mechanisms are still unclear.
The most significant finding herein is that HDF/TS cells were unsusceptible to Ras-induced alteration of gene expression (including downregulation of caveolin-1), clearly indicating that hTERT-expressing HDFs do not respond in exactly the same manner as rodent fibroblasts. The species-specific susceptibility to Ras-induced gene regulation and oncogenic transformation may be due to the differences in the actual enzymatic activity of ERK protein as Ras-induced ERK activation was attenuated in the HDF/TS cells, even though the level of ERK-phosphorylation was not significantly different (Kakumoto et al., 2006) . Thus, we propose that if we can achieve the activation of ERK in HDF/TS cells then we will be able to downregulate Caveolin-1 and transform the cells. Collectively, it is speculated that human cells may have more efficient negative-feed back mechanisms to prevent overactivation of the MAPK pathway. Considering the pleiotropic role of the MAPK pathway in tumorigenesis, rodent models do not necessarily replicate the human cell biology, and therefore, it is very difficult to fully understand the oncogenic mechanisms in human cancer by using merely the rodent systems. In order to understand human cancer and tumorigenesis more directly, employing the human materials, including xenograft models and primary culture of human tumors as well as normal human cells, will prove very important.
